ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,197,000 | -35.3% | 103,922 | -7.9% | 0.00% | -25.0% |
| Q2 2015 | $6,491,000 | -11.8% | 112,805 | -2.4% | 0.00% | -20.0% |
| Q1 2015 | $7,357,000 | +3.8% | 115,549 | +0.6% | 0.01% | 0.0% |
| Q4 2014 | $7,088,000 | +132.4% | 114,803 | +46.3% | 0.01% | +150.0% |
| Q3 2014 | $3,050,000 | -13.0% | 78,472 | -22.8% | 0.00% | 0.0% |
| Q2 2014 | $3,504,000 | -69.1% | 101,654 | -61.2% | 0.00% | -75.0% |
| Q1 2014 | $11,332,000 | +8.7% | 262,317 | +0.2% | 0.01% | 0.0% |
| Q4 2013 | $10,427,000 | +5.4% | 261,717 | -0.7% | 0.01% | -11.1% |
| Q3 2013 | $9,895,000 | +40.0% | 263,563 | +0.2% | 0.01% | +28.6% |
| Q2 2013 | $7,068,000 | – | 263,021 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |